Author:
Hu Yue-Mei,Bi Zhao-Feng,Zheng Ya,Zhang Li,Zheng Feng-Zhu,Chu Kai,Li Ya-Fei,Chen Qi,Quan Jia-Li,Hu Xiao-Wen,Huang Xing-Cheng,Zhu Kong-Xin,Wang-Jiang Ya-Hui,Jiang Han-Min,Zang Xia,Liu Dong-Lin,Yang Chang-Lin,Pan Hong-Xing,Zhang Qiu-Fen,Su Ying-Ying,Huang Shou-Jie,Sun Guang,Huang Wei-Jin,Huang Yue,Wu Ting,Zhang Jun,Xia Ning-Shao
Reference22 articles.
1. Global burden of cancer attributable to infections in 2018: A worldwide incidence analysis;de Martel;Lancet Glob Health,2020
2. A review of human carcinogens—Part B: biological agents;Bouvard;Lancet Oncol,2009
3. ICO/IARC Information Centre on HPV and Cancer (HPV Information Centre). Human papillomavirus and related diseases in the world. 2023, https://hpvcentre.net/statistics/reports/XWX.pdf?t=1693896342213.
4. ICO/IARC Information Centre on HPV and Cancer (HPV Information Centre). Human papillomavirus and related diseases in China. 2023, https://hpvcentre.net/statistics/reports/CHN.pdf?t=1693896412698.
5. Lacey CJN, Guimera N, Garland SM. Chapter 10 - Low-risk human papillomavirus: Genital warts, cancer and respiratory papillomatosis. In: Jenkins D, Bosch F X, editors. Human papillomavirus. Massachusetts: Academic Press. 2020. 165–178.